Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune response to SARS-CoV-2 in severe disease and long COVID-19
Tomonari Sumi, Kouji Harada
iScience (2022) Vol. 25, Iss. 8, pp. 104723-104723
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID
Aristo Vojdani, Elroy Vojdani, Evan Saidara, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 400-400
Open Access | Times Cited: 72
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 65
Hematological alterations associated with long COVID-19
Guilherme C. Lechuga, Carlos Morel, Salvatore G. De-Simone
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 21
Impact of Prior COVID-19 Immunization and/or Prior Infection on Immune Responses and Clinical Outcomes
Achilleas Livieratos, Charalambos Gogos, Karolina Akinosoglou
Viruses (2024) Vol. 16, Iss. 5, pp. 685-685
Open Access | Times Cited: 9
A Comparative Analysis of COVID-19 Response Measures and Their Impact on Mortality Rate
Tomokazu Konishi
COVID (2024) Vol. 4, Iss. 2, pp. 130-150
Open Access | Times Cited: 4
Thromboembolism in the Complications of Long COVID-19
Leilani A Lopes, Devendra K. Agrawal
Cardiology and Cardiovascular Medicine (2023) Vol. 07, Iss. 02
Open Access | Times Cited: 11
Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 3
AMPLITUDE EQUATIONS AND ORDER PARAMETERS OF HUMAN SARS-COV-2 INFECTIONS AND IMMUNE REACTIONS: A MODEL-BASED APPROACH
T.D. Frank
Advances in Complex Systems (2024) Vol. 27, Iss. 01n02
Closed Access | Times Cited: 3
Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles
Sinei Ramos Soares, Maria Karoliny da Silva Torres, Sandra Souza Lima, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 898-898
Open Access | Times Cited: 8
Understanding the mechanisms and treatments of long COVID to address future public health risks
Bohao Li, Junlu Bai, Yan Xiong, et al.
Life Sciences (2024) Vol. 353, pp. 122938-122938
Closed Access | Times Cited: 2
Intrinsic factors behind long COVID: III. Persistence of SARS‐CoV‐2 and its components
Nawal Abd El‐Baky, Amro Abd Al Fattah Amara, Vladimir N. Uversky, et al.
Journal of Cellular Biochemistry (2023) Vol. 125, Iss. 1
Closed Access | Times Cited: 7
Virus-mediated cell fusion of SARS-CoV-2 variants
Ava Amidei, Hana M. Dobrovolny
Mathematical Biosciences (2024) Vol. 369, pp. 109144-109144
Closed Access | Times Cited: 1
Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation study
Qingbin Hou, Jinping Jiang, Kun Na, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Proposing Bromo-Epi-Androsterone for Neurologic Long-COVID
Coad Thomas Dow
(2024)
Open Access | Times Cited: 1
Post-Acute Sequelae and Mitochondrial Aberration in SARS-CoV-2 Infection
Charles O. Ward, Beata Schlichtholz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9050-9050
Open Access | Times Cited: 1
Cellular immunity reflects the persistent symptoms among COVID-19 recovered patients in Japan
Yoshiharu Miyata, Kohjin Suzuki, Tatsuya Nagano, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Analysis of the In-Host Dynamics of Tuberculosis and SARS-CoV-2 Coinfection
A. M. Ełaiw, Afnan Al Agha
Mathematics (2023) Vol. 11, Iss. 5, pp. 1104-1104
Open Access | Times Cited: 2
Immune Response after SARS-CoV-2 Infection with Residual Post-COVID Symptoms
Tanyaporn Pongkunakorn, Thamonwan Manosan, Apinya Surawit, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1413-1413
Open Access | Times Cited: 2
Recent developments in the immunopathology of COVID-19
Yadong Gao, Huanping Zhang, Yuanli Sun, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 4
Reconsideration of interferon treatment for viral diseases: Lessons from SARS, MERS, and COVID-19
Dan Ma, Ximin Wang, Min Li, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110485-110485
Open Access | Times Cited: 2
Oncolysis by SARS-CoV-2: modeling and analysis
Afnan Al Agha, Hakim AL Garalleh
AIMS Mathematics (2024) Vol. 9, Iss. 3, pp. 7212-7252
Open Access
Analysis of a reaction-diffusion oncolytic SARS-CoV-2 model
Afnan Al Agha
Modeling Earth Systems and Environment (2024) Vol. 10, Iss. 4, pp. 4641-4662
Closed Access
Hub genes identification and validation of ferroptosis in SARS-CoV-2 induced ARDS: perspective from transcriptome analysis
Yutang Li, Li Tang, Fang Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Vaccine and antiviral drug promise for preventing post-acute sequelae of COVID-19, and their combination for its treatment
Tomonari Sumi, Kouji Harada
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top